DiaSorin SpA (DIAS)

Currency in EUR
85.00
-1.20(-1.39%)
Closed·
DIAS Scorecard
Full Analysis
High shareholder yield
DIAS is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
85.0086.52
52 wk Range
84.14112.35
Key Statistics
Prev. Close
86.2
Open
86.2
Day's Range
85-86.52
52 wk Range
84.14-112.35
Volume
185.46K
Average Volume (3m)
161.47K
1-Year Change
-15.12%
Book Value / Share
28.43
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DIAS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
106.53
Upside
+25.32%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 6 consecutive years

DiaSorin SpA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

DiaSorin SpA Company Profile

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Employees
3279
Market
Italy

Compare DIAS to Peers and Sector

Metrics to compare
DIAS
Peers
Sector
Relationship
P/E Ratio
24.3x7.4x−0.5x
PEG Ratio
-0.370.00
Price/Book
3.0x1.8x2.6x
Price / LTM Sales
3.8x1.5x3.3x
Upside (Analyst Target)
21.8%30.6%45.1%
Fair Value Upside
Unlock19.6%7.4%Unlock

Analyst Ratings

5 Buy
6 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 106.53
(+25.32% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
1.39%
Industry Median 1.55%
Annualised payout
1.20
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
1.12 / 1.12
Revenue / Forecast
306.00M / 308.18M
EPS Revisions
Last 90 days

DIAS Income Statement

People Also Watch

5.120
NEXII
+0.79%
32.4700
GASI
+1.88%
19.220
PST
+2.21%
15.580
BMED
+2.91%
5.130
SRG
+0.94%

FAQ

What Stock Exchange Does Diasorin Trade On?

Diasorin is listed and trades on the Milan Stock Exchange stock exchange.

What Is the Stock Symbol for Diasorin?

The stock symbol for Diasorin is "DIAS."

What Is the Diasorin Market Cap?

As of today, Diasorin market cap is 4.59B.

What Is Diasorin's Earnings Per Share (TTM)?

The Diasorin EPS (TTM) is 0.00.

When Is the Next Diasorin Earnings Date?

Diasorin will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is DIAS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Diasorin Stock Split?

Diasorin has split 0 times.

How Many Employees Does Diasorin Have?

Diasorin has 3279 employees.

What is the current trading status of Diasorin (DIAS)?

As of 04 Aug 2025, Diasorin (DIAS) is trading at a price of 85.00, with a previous close of 86.20. The stock has fluctuated within a day range of 85.00 to 86.52, while its 52-week range spans from 84.14 to 112.35.

What Is Diasorin (DIAS) Price Target According to Analysts?

The average 12-month price target for Diasorin is EUR106.525, with a high estimate of EUR122 and a low estimate of EUR82. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +25.32% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.